Venetoclax in acute myeloid leukemia

被引：3
|
作者：
Bruzzese, Antonella [1 ,5 ]
Martino, Enrica Antonia [1 ]
Mendicino, Francesco [1 ]
Lucia, Eugenio [1 ]
Olivito, Virginia [1 ]
Neri, Antonino [2 ]
Morabito, Fortunato [3 ]
Vigna, Ernesto [1 ]
Gentile, Massimo [1 ,4 ,5 ]
机构：
[1] Azienda Osped Annunziata, Hematol Unit, Cosenza, Italy
[2] Sci Directorate IRCCS Reggio Emilia, Reggio Emilia, Italy
[3] AO Cosenza, Biotechnol Res Unit, Cosenza, Italy
[4] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy
[5] AO Cosenza, Hematol Unit, Viale Repubbl Snc, I-87100 Cosenza, Italy
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2023年 / 32卷 / 04期
关键词：
Venetoclax; AML; therapy; INTENSIVE CHEMOTHERAPY; SINGLE-CENTER; CELL-DEATH; CYTARABINE; RESISTANCE; DAUNORUBICIN; AZACITIDINE; COMBINATION; INHIBITION; ABT-199;
D O I：
10.1080/13543784.2023.2193679
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：271 / 276
页数：6
相关论文
共 50 条
  • [31] Utility of therapeutic drug monitoring of venetoclax in acute myeloid leukemia
    Kobayashi, Masayuki
    Yasu, Takeo
    Suzaki, Ken
    Kosugi, Nobuharu
    MEDICAL ONCOLOGY, 2022, 39 (12)
  • [32] Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate
    Renshi Kawakatsu
    Kenjiro Tadagaki
    Kenta Yamasaki
    Tatsushi Yoshida
    Scientific Reports, 14
  • [33] Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
    Gibson, Amber
    Dickson, Samantha
    McCall, David
    Garcia, Miriam
    Connors, Jeremy
    He, Jiasen
    Roth, Michael
    Nunez, Cesar
    Cuglievan, Branko
    PEDIATRIC BLOOD & CANCER, 2024,
  • [34] Venetoclax Combined with Azacitidine and Homoharringtonine in Adults with Secondary Acute Myeloid Leukemia
    Huang, Fei
    Chen, Yu
    Shi, Zhongxun
    Huang, Huijun
    Li, Jianyong
    Shen, Wenyi
    BLOOD, 2023, 142
  • [35] The combination of venetoclax and quercetin exerts a cytotoxic effect on acute myeloid leukemia
    Renshi Kawakatsu
    Kenjiro Tadagaki
    Kenta Yamasaki
    Yasumichi Kuwahara
    Shinichiro Nakada
    Tatsushi Yoshida
    Scientific Reports, 14 (1)
  • [36] How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia
    Maiti, Abhishek
    Konopleva, Marina Y.
    CANCER JOURNAL, 2022, 28 (01): : 2 - 13
  • [37] Harnessing the Therapeutic Value of Venetoclax: A Breakthrough Therapy in Acute Myeloid Leukemia
    Wei, Andrew H.
    Roboz, Gail J.
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (25) : 2742 - +
  • [38] Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?
    Brancati, Serena
    Gozzo, Lucia
    Romano, Giovanni Luca
    Vetro, Calogero
    Dulcamare, Ilaria
    Maugeri, Cinzia
    Parisi, Marina
    Longo, Laura
    Vitale, Daniela Cristina
    Di Raimondo, Francesco
    Drago, Filippo
    CANCERS, 2022, 14 (01)
  • [39] Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
    Chen, Xufeng
    Glytsou, Christina
    Zhou, Hua
    Narang, Sonali
    Reyna, Denis E.
    Lopez, Andrea
    Sakellaropoulos, Theodore
    Gong, Yixiao
    Kloetgen, Andreas
    Yap, Yoon Sing
    Wang, Eric
    Gavathiotis, Evripidis
    Tsirigos, Aristotelis
    Tibes, Raoul
    Aifantis, Iannis
    CANCER DISCOVERY, 2019, 9 (07) : 890 - 909
  • [40] Anlotinib synergizes with venetoclax to induce mitotic catastrophe in acute myeloid leukemia
    Wang, Dan
    He, Jing
    Liu, Siyang
    Zhang, Haixia
    Tang, Daolin
    Chen, Pan
    Yang, Minghua
    CANCER LETTERS, 2024, 593
12345